Diagnostic or prognostic study
Predicting Survival After Impella Implantation in Patients with Cardiogenic Shock: The J-PVAD Risk Score
- Risk prediction model development and validation study (registry)
- nationwide registry
- random derivation/validation split
- backward stepwise logistic regression
Authors' conclusion
The J-PVAD risk score can be calculated using variables easily obtained in routine clinical practice. It helps the accurate stratification of mortality risk and facilitates clinical decision-making.
Study context
- Population
- Patients with cardiogenic shock requiring Impella, all Impella cases in Japan (J-PVAD registry)
- Participants
- 1,701 vs 850
- Comparison
- Derivation vs Validation
- Derivationn = 1,701
- Validationn = 850
- Outcome
- In-hospital mortality
Performance
As reported in the abstract
J-PVAD risk score for in-hospital mortality
| Test or model | Value | AUC |
|---|---|---|
| Derivation | 43.8% | 0.76 (95% CI 0.73-0.78) |
Original publication
Predicting Survival After Impella Implantation in Patients with Cardiogenic Shock: The J-PVAD Risk Score. Eur J Heart Fail. Published 19 September 2024. doi:10.1002/ejhf.3471
Summarised from the published abstract; every number is checked against it